Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan;50(1):55-61.
doi: 10.1128/AAC.50.1.55-61.2006.

Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections

Raphael Saginur  1 , Melissa Stdenis, Wendy Ferris, Shawn D Aaron, Francis Chan, Craig Lee, Karam Ramotar
Affiliations

Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections

Raphael Saginur et al. Antimicrob Agents Chemother. 2006 Jan.

Abstract

Standardized susceptibility testing fails to predict in vivo resistance of device-related infections to antimicrobials. We assessed agents and combinations of antimicrobials against clinical isolates of Staphylococcus epidermidis and S. aureus (methicillin-resistant S. aureus and methicillin-sensitive S. aureus) retrieved from device-associated infections. Isolates were grown planktonically and as biofilms. Biofilm cultures of the organisms were found to be much more resistant to inhibitory and bactericidal effects of single and combination antibiotics than planktonic cultures (P < 0.001). Rifampin was the most common constituent of antibiotic combinations active against staphylococcal biofilms. Other frequently effective antimicrobials were vancomycin and fusidic acid. Susceptibility testing involving biofilm-associated bacteria suggests new options for combination antibiotic therapy.

PubMed Disclaimer

References

    1. Aaron, S. D., W. Ferris, D. A. Henry, D. P. Speert, and N. E. MacDonald. 2000. Multiple combination bactericidal antibiotic testing for cystic fibrosis patients infected with Burkholderia cepacia. Am. J. Resp. Crit. Care Med. 161:1206-1212. - PubMed
    1. Aaron, S. D., W. Ferris, K. Ramotar, K. Vandemheem, F. Chan, and R. Saginur. 2002. Single and combination antibiotic susceptibilities of planktonic, adherent and biofilm-grown Pseudomonas aeruginosa cultured from CF sputum. Clin. Microbiol. 40:4172-4179. - PMC - PubMed
    1. Anderson, J. M., and R. E. Marchant. 2000. Biomaterials: factors favoring colonization and infection, p. 89-109. In F. A. Waldvogel and A. L. Bisno (ed.), Infections associated with biomedical devices, 3rd ed. ASM Press, Washington, D.C.
    1. Andrews, J., and BSAC Working Party Report on Susceptibility Testing. 2001. Determination of inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl. 1):48-71.
    1. Ceri, H., M. F. Olsen, C. Stremick, R. R. Reid, D. Morck, and A. Buret. 1999. The Calgary Biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37:1771-1776. - PMC - PubMed

Publication types

MeSH terms